Skip to main content
. 2021 Jul 15;13(7):7906–7913.

Table 1.

General data of patients

Category Joint group (n=95) Control group (n=79) t/χ2 P
Course of disease (d) 2.71±0.28 2.76±0.31
Gender 0.112 0.738
    Man 59 (62.11) 51 (64.56)
    Woman 36 (37.89) 28 (35.44)
Age 61.59±4.06 60.48±4.16
Complicated with hypertension 0.034 0.854
    Yes 24 (25.26) 19 (24.05)
    No 71 (74.74) 60 (75.95)
Complicated with diabetes 0.247 0.619
    Yes 21 (22.11) 20 (25.32)
    No 74 (77.89) 59 (74.68)
Complicated with hyperlipidemia 0.043 0.836
    Yes 43 (45.26) 37 (46.84)
    No 52 (54.74) 42 (53.16)
Risk degree 4.092 0.129
    Low risk 36 (37.89) 31 (39.24)
    Moderate risk 39 (41.05) 40 (50.63)
    High risk 20 (21.05) 8 (10.13)
Disease type 1.172 0.557
    Initial exertional angina pectoris 29 (30.53) 20 (25.32)
    Deteriorating exertional angina pectoris 18 (18.95) 14 (17.72)
    Resting angina pectoris 45 (47.37) 45 (56.96)
NYHA classification of cardiac function 0.195 0.978
    Class I 45 (47.37) 35 (44.30)
    Class II 30 (31.58) 27 (34.18)
    Class III 19 (20.00) 16 (20.25)
    Class IV 1 (1.05) 1 (1.27)